Clinical Trials Browser

Withdrawn × Valproic Acid × Clear all

NCT00181220 2020-05-18

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma

Phase 1 Withdrawn

Nasopharyngeal Carcinoma

NCT01861990 2015-05-22

Valproic Acid in Childhood Progressive Brain Tumors

Phase 1 Withdrawn

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT01011998 2011-09-27

A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

Phase 2 Withdrawn

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive